There are 2789 resources available
1155P - Univariable and multivariable two-sample Mendelian randomization investigating the effects of leisure sedentary behavior on the risk of lung cancer
Presenter: Haoxin Peng
Session: ePoster Display
1115P - Beyond classic hereditary neuroendocrine tumors (NET) syndromes
Presenter: Carmen Castillo Manzano
Session: ePoster Display
1230P - Elderly patients treated with afatinib in clinical practice: Final results of the GIDEON study in EGFR mutated NSCLC in Germany
Presenter: Wolfgang M Brueckl
Session: ePoster Display
1231P - Characterization and management of mobocertinib (TAK-788) induced skin toxicity in patients with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) who previously received platinum chemotherapy
Presenter: James Chih-Hsin Yang
Session: ePoster Display
1232P - Understanding the diagnostic and treatment landscape in EGFRm advanced non-small cell lung cancer (aNSCLC) patients with exon 20 insertion mutations (Ex20ins)
Presenter: Hollie Bailey
Session: ePoster Display
1280P - Sitravatinib + tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
Presenter: Qing Zhou
Session: ePoster Display
1282P - Biology of immune resistance in oncogenic driven advanced non-small cell lung cancer (aNSCLC)
Presenter: Mihaela Aldea
Session: ePoster Display
1120P - The prognostic and predictive roles of Ki67 and functional imaging tests in patients (pts) with metastatic pheochromocytoma or paraganglioma (mPPGL) treated with chemotherapy
Presenter: Samara Pacheco
Session: ePoster Display
1284P - Sitravatinib + tislelizumab in patients with anti-PD-(L)1 refractory/resistant metastatic NSCLC
Presenter: Bo Gao
Session: ePoster Display
1285P - Final analysis of TORG1936/AMBITIOUS: Phase II study of atezolizumab for pretreated non-small cell lung cancer with idiopathic interstitial pneumonia
Presenter: Yuki Sato
Session: ePoster Display